Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04230759
Title Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group (RADIANCE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Goethe University

anal squamous cell carcinoma

anal canal squamous cell carcinoma


Durvalumab + Fluorouracil + Mitomycin C

Fluorouracil + Mitomycin C

Age Groups: senior | adult
Covered Countries DEU

No variant requirements are available.